The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nimesulide Market Research Report 2025
Synopsis
Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.
The global Nimesulide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nimesulide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nimesulide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nimesulide include Helsinn, Therabel, Boehringer Ingelheim, Merck, Roche, Novartis, Medea Research, Chinoin and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nimesulide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nimesulide.
Report Scope
The Nimesulide market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nimesulide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nimesulide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Helsinn
Therabel
Boehringer Ingelheim
Merck
Roche
Novartis
Medea Research
Chinoin
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Lepu Pharmaceutical
Nanchang Feihong Pharmaceutical
Sinopharm
Guangdong Longxin Pharmaceutical
Kangzhi Pharmaceutical
Hubei Shubang Pharmaceutical
Mudanjiang Lingtai Pharmaceutical
Guizhou Jisheng Pharmaceutical
Tianjin Hezhi Pharmaceutical Group
Guangdong Yishu Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Hainan Huluwa Pharmaceutical
Nanjing Zhengke Pharmaceutical
Segment by Type
Tablets
Capsule
Granules
Other
Segment by Application
Chronic Arthritis
Primary Dysmenorrhea
Traumatic Pain
Post-Operative Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nimesulide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nimesulide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.
The global Nimesulide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nimesulide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nimesulide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nimesulide include Helsinn, Therabel, Boehringer Ingelheim, Merck, Roche, Novartis, Medea Research, Chinoin and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nimesulide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nimesulide.
Report Scope
The Nimesulide market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nimesulide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nimesulide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Helsinn
Therabel
Boehringer Ingelheim
Merck
Roche
Novartis
Medea Research
Chinoin
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Lepu Pharmaceutical
Nanchang Feihong Pharmaceutical
Sinopharm
Guangdong Longxin Pharmaceutical
Kangzhi Pharmaceutical
Hubei Shubang Pharmaceutical
Mudanjiang Lingtai Pharmaceutical
Guizhou Jisheng Pharmaceutical
Tianjin Hezhi Pharmaceutical Group
Guangdong Yishu Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Hainan Huluwa Pharmaceutical
Nanjing Zhengke Pharmaceutical
Segment by Type
Tablets
Capsule
Granules
Other
Segment by Application
Chronic Arthritis
Primary Dysmenorrhea
Traumatic Pain
Post-Operative Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nimesulide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nimesulide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nimesulide Market Overview
1.1 Product Overview and Scope of Nimesulide
1.2 Nimesulide Segment by Type
1.2.1 Global Nimesulide Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Granules
1.2.5 Other
1.3 Nimesulide Segment by Application
1.3.1 Global Nimesulide Market Value by Application: (2024-2030)
1.3.2 Chronic Arthritis
1.3.3 Primary Dysmenorrhea
1.3.4 Traumatic Pain
1.3.5 Post-Operative Pain
1.3.6 Other
1.4 Global Nimesulide Market Size Estimates and Forecasts
1.4.1 Global Nimesulide Revenue 2019-2030
1.4.2 Global Nimesulide Sales 2019-2030
1.4.3 Global Nimesulide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nimesulide Market Competition by Manufacturers
2.1 Global Nimesulide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nimesulide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nimesulide Average Price by Manufacturers (2019-2024)
2.4 Global Nimesulide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nimesulide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nimesulide, Product Type & Application
2.7 Nimesulide Market Competitive Situation and Trends
2.7.1 Nimesulide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nimesulide Players Market Share by Revenue
2.7.3 Global Nimesulide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nimesulide Retrospective Market Scenario by Region
3.1 Global Nimesulide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nimesulide Global Nimesulide Sales by Region: 2019-2030
3.2.1 Global Nimesulide Sales by Region: 2019-2024
3.2.2 Global Nimesulide Sales by Region: 2025-2030
3.3 Global Nimesulide Global Nimesulide Revenue by Region: 2019-2030
3.3.1 Global Nimesulide Revenue by Region: 2019-2024
3.3.2 Global Nimesulide Revenue by Region: 2025-2030
3.4 North America Nimesulide Market Facts & Figures by Country
3.4.1 North America Nimesulide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nimesulide Sales by Country (2019-2030)
3.4.3 North America Nimesulide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nimesulide Market Facts & Figures by Country
3.5.1 Europe Nimesulide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nimesulide Sales by Country (2019-2030)
3.5.3 Europe Nimesulide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nimesulide Market Facts & Figures by Country
3.6.1 Asia Pacific Nimesulide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nimesulide Sales by Country (2019-2030)
3.6.3 Asia Pacific Nimesulide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nimesulide Market Facts & Figures by Country
3.7.1 Latin America Nimesulide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nimesulide Sales by Country (2019-2030)
3.7.3 Latin America Nimesulide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nimesulide Market Facts & Figures by Country
3.8.1 Middle East and Africa Nimesulide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nimesulide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nimesulide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nimesulide Sales by Type (2019-2030)
4.1.1 Global Nimesulide Sales by Type (2019-2024)
4.1.2 Global Nimesulide Sales by Type (2025-2030)
4.1.3 Global Nimesulide Sales Market Share by Type (2019-2030)
4.2 Global Nimesulide Revenue by Type (2019-2030)
4.2.1 Global Nimesulide Revenue by Type (2019-2024)
4.2.2 Global Nimesulide Revenue by Type (2025-2030)
4.2.3 Global Nimesulide Revenue Market Share by Type (2019-2030)
4.3 Global Nimesulide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nimesulide Sales by Application (2019-2030)
5.1.1 Global Nimesulide Sales by Application (2019-2024)
5.1.2 Global Nimesulide Sales by Application (2025-2030)
5.1.3 Global Nimesulide Sales Market Share by Application (2019-2030)
5.2 Global Nimesulide Revenue by Application (2019-2030)
5.2.1 Global Nimesulide Revenue by Application (2019-2024)
5.2.2 Global Nimesulide Revenue by Application (2025-2030)
5.2.3 Global Nimesulide Revenue Market Share by Application (2019-2030)
5.3 Global Nimesulide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Helsinn
6.1.1 Helsinn Corporation Information
6.1.2 Helsinn Description and Business Overview
6.1.3 Helsinn Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Helsinn Nimesulide Product Portfolio
6.1.5 Helsinn Recent Developments/Updates
6.2 Therabel
6.2.1 Therabel Corporation Information
6.2.2 Therabel Description and Business Overview
6.2.3 Therabel Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Therabel Nimesulide Product Portfolio
6.2.5 Therabel Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Nimesulide Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Nimesulide Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Nimesulide Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Nimesulide Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Medea Research
6.6.1 Medea Research Corporation Information
6.6.2 Medea Research Description and Business Overview
6.6.3 Medea Research Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medea Research Nimesulide Product Portfolio
6.7.5 Medea Research Recent Developments/Updates
6.8 Chinoin
6.8.1 Chinoin Corporation Information
6.8.2 Chinoin Description and Business Overview
6.8.3 Chinoin Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chinoin Nimesulide Product Portfolio
6.8.5 Chinoin Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Nimesulide Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Alter
6.10.1 Alter Corporation Information
6.10.2 Alter Description and Business Overview
6.10.3 Alter Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alter Nimesulide Product Portfolio
6.10.5 Alter Recent Developments/Updates
6.11 Bayer
6.11.1 Bayer Corporation Information
6.11.2 Bayer Nimesulide Description and Business Overview
6.11.3 Bayer Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bayer Nimesulide Product Portfolio
6.11.5 Bayer Recent Developments/Updates
6.12 Rafa Laboratories
6.12.1 Rafa Laboratories Corporation Information
6.12.2 Rafa Laboratories Nimesulide Description and Business Overview
6.12.3 Rafa Laboratories Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Rafa Laboratories Nimesulide Product Portfolio
6.12.5 Rafa Laboratories Recent Developments/Updates
6.13 Grunenthal
6.13.1 Grunenthal Corporation Information
6.13.2 Grunenthal Nimesulide Description and Business Overview
6.13.3 Grunenthal Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Grunenthal Nimesulide Product Portfolio
6.13.5 Grunenthal Recent Developments/Updates
6.14 Pfizer
6.14.1 Pfizer Corporation Information
6.14.2 Pfizer Nimesulide Description and Business Overview
6.14.3 Pfizer Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Pfizer Nimesulide Product Portfolio
6.14.5 Pfizer Recent Developments/Updates
6.15 Sanofi
6.15.1 Sanofi Corporation Information
6.15.2 Sanofi Nimesulide Description and Business Overview
6.15.3 Sanofi Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sanofi Nimesulide Product Portfolio
6.15.5 Sanofi Recent Developments/Updates
6.16 Italfarmaco
6.16.1 Italfarmaco Corporation Information
6.16.2 Italfarmaco Nimesulide Description and Business Overview
6.16.3 Italfarmaco Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Italfarmaco Nimesulide Product Portfolio
6.16.5 Italfarmaco Recent Developments/Updates
6.17 Lepu Pharmaceutical
6.17.1 Lepu Pharmaceutical Corporation Information
6.17.2 Lepu Pharmaceutical Nimesulide Description and Business Overview
6.17.3 Lepu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Lepu Pharmaceutical Nimesulide Product Portfolio
6.17.5 Lepu Pharmaceutical Recent Developments/Updates
6.18 Nanchang Feihong Pharmaceutical
6.18.1 Nanchang Feihong Pharmaceutical Corporation Information
6.18.2 Nanchang Feihong Pharmaceutical Nimesulide Description and Business Overview
6.18.3 Nanchang Feihong Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Nanchang Feihong Pharmaceutical Nimesulide Product Portfolio
6.18.5 Nanchang Feihong Pharmaceutical Recent Developments/Updates
6.19 Sinopharm
6.19.1 Sinopharm Corporation Information
6.19.2 Sinopharm Nimesulide Description and Business Overview
6.19.3 Sinopharm Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Sinopharm Nimesulide Product Portfolio
6.19.5 Sinopharm Recent Developments/Updates
6.20 Guangdong Longxin Pharmaceutical
6.20.1 Guangdong Longxin Pharmaceutical Corporation Information
6.20.2 Guangdong Longxin Pharmaceutical Nimesulide Description and Business Overview
6.20.3 Guangdong Longxin Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Guangdong Longxin Pharmaceutical Nimesulide Product Portfolio
6.20.5 Guangdong Longxin Pharmaceutical Recent Developments/Updates
6.21 Kangzhi Pharmaceutical
6.21.1 Kangzhi Pharmaceutical Corporation Information
6.21.2 Kangzhi Pharmaceutical Nimesulide Description and Business Overview
6.21.3 Kangzhi Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Kangzhi Pharmaceutical Nimesulide Product Portfolio
6.21.5 Kangzhi Pharmaceutical Recent Developments/Updates
6.22 Hubei Shubang Pharmaceutical
6.22.1 Hubei Shubang Pharmaceutical Corporation Information
6.22.2 Hubei Shubang Pharmaceutical Nimesulide Description and Business Overview
6.22.3 Hubei Shubang Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Hubei Shubang Pharmaceutical Nimesulide Product Portfolio
6.22.5 Hubei Shubang Pharmaceutical Recent Developments/Updates
6.23 Mudanjiang Lingtai Pharmaceutical
6.23.1 Mudanjiang Lingtai Pharmaceutical Corporation Information
6.23.2 Mudanjiang Lingtai Pharmaceutical Nimesulide Description and Business Overview
6.23.3 Mudanjiang Lingtai Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Mudanjiang Lingtai Pharmaceutical Nimesulide Product Portfolio
6.23.5 Mudanjiang Lingtai Pharmaceutical Recent Developments/Updates
6.24 Guizhou Jisheng Pharmaceutical
6.24.1 Guizhou Jisheng Pharmaceutical Corporation Information
6.24.2 Guizhou Jisheng Pharmaceutical Nimesulide Description and Business Overview
6.24.3 Guizhou Jisheng Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Guizhou Jisheng Pharmaceutical Nimesulide Product Portfolio
6.24.5 Guizhou Jisheng Pharmaceutical Recent Developments/Updates
6.25 Tianjin Hezhi Pharmaceutical Group
6.25.1 Tianjin Hezhi Pharmaceutical Group Corporation Information
6.25.2 Tianjin Hezhi Pharmaceutical Group Nimesulide Description and Business Overview
6.25.3 Tianjin Hezhi Pharmaceutical Group Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Tianjin Hezhi Pharmaceutical Group Nimesulide Product Portfolio
6.25.5 Tianjin Hezhi Pharmaceutical Group Recent Developments/Updates
6.26 Guangdong Yishu Pharmaceutical
6.26.1 Guangdong Yishu Pharmaceutical Corporation Information
6.26.2 Guangdong Yishu Pharmaceutical Nimesulide Description and Business Overview
6.26.3 Guangdong Yishu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Guangdong Yishu Pharmaceutical Nimesulide Product Portfolio
6.26.5 Guangdong Yishu Pharmaceutical Recent Developments/Updates
6.27 Guangzhou Baiyunshan Pharmaceutical
6.27.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
6.27.2 Guangzhou Baiyunshan Pharmaceutical Nimesulide Description and Business Overview
6.27.3 Guangzhou Baiyunshan Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Guangzhou Baiyunshan Pharmaceutical Nimesulide Product Portfolio
6.27.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
6.28 Hainan Huluwa Pharmaceutical
6.28.1 Hainan Huluwa Pharmaceutical Corporation Information
6.28.2 Hainan Huluwa Pharmaceutical Nimesulide Description and Business Overview
6.28.3 Hainan Huluwa Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.28.4 Hainan Huluwa Pharmaceutical Nimesulide Product Portfolio
6.28.5 Hainan Huluwa Pharmaceutical Recent Developments/Updates
6.29 Nanjing Zhengke Pharmaceutical
6.29.1 Nanjing Zhengke Pharmaceutical Corporation Information
6.29.2 Nanjing Zhengke Pharmaceutical Nimesulide Description and Business Overview
6.29.3 Nanjing Zhengke Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2019-2024)
6.29.4 Nanjing Zhengke Pharmaceutical Nimesulide Product Portfolio
6.29.5 Nanjing Zhengke Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nimesulide Industry Chain Analysis
7.2 Nimesulide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nimesulide Production Mode & Process
7.4 Nimesulide Sales and Marketing
7.4.1 Nimesulide Sales Channels
7.4.2 Nimesulide Distributors
7.5 Nimesulide Customers
8 Nimesulide Market Dynamics
8.1 Nimesulide Industry Trends
8.2 Nimesulide Market Drivers
8.3 Nimesulide Market Challenges
8.4 Nimesulide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nimesulide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nimesulide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nimesulide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nimesulide Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Nimesulide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nimesulide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nimesulide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nimesulide Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nimesulide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nimesulide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nimesulide, Product Type & Application
Table 12. Global Key Manufacturers of Nimesulide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nimesulide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nimesulide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nimesulide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nimesulide Sales by Region (2019-2024) & (KG)
Table 18. Global Nimesulide Sales Market Share by Region (2019-2024)
Table 19. Global Nimesulide Sales by Region (2025-2030) & (KG)
Table 20. Global Nimesulide Sales Market Share by Region (2025-2030)
Table 21. Global Nimesulide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nimesulide Revenue Market Share by Region (2019-2024)
Table 23. Global Nimesulide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nimesulide Revenue Market Share by Region (2025-2030)
Table 25. North America Nimesulide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nimesulide Sales by Country (2019-2024) & (KG)
Table 27. North America Nimesulide Sales by Country (2025-2030) & (KG)
Table 28. North America Nimesulide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nimesulide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nimesulide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nimesulide Sales by Country (2019-2024) & (KG)
Table 32. Europe Nimesulide Sales by Country (2025-2030) & (KG)
Table 33. Europe Nimesulide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nimesulide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nimesulide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nimesulide Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Nimesulide Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Nimesulide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nimesulide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nimesulide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nimesulide Sales by Country (2019-2024) & (KG)
Table 42. Latin America Nimesulide Sales by Country (2025-2030) & (KG)
Table 43. Latin America Nimesulide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nimesulide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nimesulide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nimesulide Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Nimesulide Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Nimesulide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nimesulide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nimesulide Sales (KG) by Type (2019-2024)
Table 51. Global Nimesulide Sales (KG) by Type (2025-2030)
Table 52. Global Nimesulide Sales Market Share by Type (2019-2024)
Table 53. Global Nimesulide Sales Market Share by Type (2025-2030)
Table 54. Global Nimesulide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nimesulide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nimesulide Revenue Market Share by Type (2019-2024)
Table 57. Global Nimesulide Revenue Market Share by Type (2025-2030)
Table 58. Global Nimesulide Price (US$/G) by Type (2019-2024)
Table 59. Global Nimesulide Price (US$/G) by Type (2025-2030)
Table 60. Global Nimesulide Sales (KG) by Application (2019-2024)
Table 61. Global Nimesulide Sales (KG) by Application (2025-2030)
Table 62. Global Nimesulide Sales Market Share by Application (2019-2024)
Table 63. Global Nimesulide Sales Market Share by Application (2025-2030)
Table 64. Global Nimesulide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nimesulide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nimesulide Revenue Market Share by Application (2019-2024)
Table 67. Global Nimesulide Revenue Market Share by Application (2025-2030)
Table 68. Global Nimesulide Price (US$/G) by Application (2019-2024)
Table 69. Global Nimesulide Price (US$/G) by Application (2025-2030)
Table 70. Helsinn Corporation Information
Table 71. Helsinn Description and Business Overview
Table 72. Helsinn Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Helsinn Nimesulide Product
Table 74. Helsinn Recent Developments/Updates
Table 75. Therabel Corporation Information
Table 76. Therabel Description and Business Overview
Table 77. Therabel Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Therabel Nimesulide Product
Table 79. Therabel Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Nimesulide Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Merck Nimesulide Product
Table 89. Merck Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Roche Nimesulide Product
Table 94. Roche Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Novartis Nimesulide Product
Table 99. Novartis Recent Developments/Updates
Table 100. Medea Research Corporation Information
Table 101. Medea Research Description and Business Overview
Table 102. Medea Research Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Medea Research Nimesulide Product
Table 104. Medea Research Recent Developments/Updates
Table 105. Chinoin Corporation Information
Table 106. Chinoin Description and Business Overview
Table 107. Chinoin Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Chinoin Nimesulide Product
Table 109. Chinoin Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. GSK Nimesulide Product
Table 114. GSK Recent Developments/Updates
Table 115. Alter Corporation Information
Table 116. Alter Description and Business Overview
Table 117. Alter Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Alter Nimesulide Product
Table 119. Alter Recent Developments/Updates
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Bayer Nimesulide Product
Table 124. Bayer Recent Developments/Updates
Table 125. Rafa Laboratories Corporation Information
Table 126. Rafa Laboratories Description and Business Overview
Table 127. Rafa Laboratories Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Rafa Laboratories Nimesulide Product
Table 129. Rafa Laboratories Recent Developments/Updates
Table 130. Grunenthal Corporation Information
Table 131. Grunenthal Description and Business Overview
Table 132. Grunenthal Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Grunenthal Nimesulide Product
Table 134. Grunenthal Recent Developments/Updates
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Pfizer Nimesulide Product
Table 139. Pfizer Recent Developments/Updates
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Sanofi Nimesulide Product
Table 144. Sanofi Recent Developments/Updates
Table 145. Italfarmaco Corporation Information
Table 146. Italfarmaco Description and Business Overview
Table 147. Italfarmaco Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Italfarmaco Nimesulide Product
Table 149. Italfarmaco Recent Developments/Updates
Table 150. Lepu Pharmaceutical Corporation Information
Table 151. Lepu Pharmaceutical Description and Business Overview
Table 152. Lepu Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. Lepu Pharmaceutical Nimesulide Product
Table 154. Lepu Pharmaceutical Recent Developments/Updates
Table 155. Nanchang Feihong Pharmaceutical Corporation Information
Table 156. Nanchang Feihong Pharmaceutical Description and Business Overview
Table 157. Nanchang Feihong Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. Nanchang Feihong Pharmaceutical Nimesulide Product
Table 159. Nanchang Feihong Pharmaceutical Recent Developments/Updates
Table 160. Sinopharm Corporation Information
Table 161. Sinopharm Description and Business Overview
Table 162. Sinopharm Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 163. Sinopharm Nimesulide Product
Table 164. Sinopharm Recent Developments/Updates
Table 165. Guangdong Longxin Pharmaceutical Corporation Information
Table 166. Guangdong Longxin Pharmaceutical Description and Business Overview
Table 167. Guangdong Longxin Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 168. Guangdong Longxin Pharmaceutical Nimesulide Product
Table 169. Guangdong Longxin Pharmaceutical Recent Developments/Updates
Table 170. Kangzhi Pharmaceutical Corporation Information
Table 171. Kangzhi Pharmaceutical Description and Business Overview
Table 172. Kangzhi Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 173. Kangzhi Pharmaceutical Nimesulide Product
Table 174. Kangzhi Pharmaceutical Recent Developments/Updates
Table 175. Hubei Shubang Pharmaceutical Corporation Information
Table 176. Hubei Shubang Pharmaceutical Description and Business Overview
Table 177. Hubei Shubang Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 178. Hubei Shubang Pharmaceutical Nimesulide Product
Table 179. Hubei Shubang Pharmaceutical Recent Developments/Updates
Table 180. Mudanjiang Lingtai Pharmaceutical Corporation Information
Table 181. Mudanjiang Lingtai Pharmaceutical Description and Business Overview
Table 182. Mudanjiang Lingtai Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 183. Mudanjiang Lingtai Pharmaceutical Nimesulide Product
Table 184. Mudanjiang Lingtai Pharmaceutical Recent Developments/Updates
Table 185. Guizhou Jisheng Pharmaceutical Corporation Information
Table 186. Guizhou Jisheng Pharmaceutical Description and Business Overview
Table 187. Guizhou Jisheng Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 188. Guizhou Jisheng Pharmaceutical Nimesulide Product
Table 189. Guizhou Jisheng Pharmaceutical Recent Developments/Updates
Table 190. Tianjin Hezhi Pharmaceutical Group Corporation Information
Table 191. Tianjin Hezhi Pharmaceutical Group Description and Business Overview
Table 192. Tianjin Hezhi Pharmaceutical Group Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 193. Tianjin Hezhi Pharmaceutical Group Nimesulide Product
Table 194. Tianjin Hezhi Pharmaceutical Group Recent Developments/Updates
Table 195. Guangdong Yishu Pharmaceutical Corporation Information
Table 196. Guangdong Yishu Pharmaceutical Description and Business Overview
Table 197. Guangdong Yishu Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 198. Guangdong Yishu Pharmaceutical Nimesulide Product
Table 199. Guangdong Yishu Pharmaceutical Recent Developments/Updates
Table 200. Guangzhou Baiyunshan Pharmaceutical Corporation Information
Table 201. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
Table 202. Guangzhou Baiyunshan Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 203. Guangzhou Baiyunshan Pharmaceutical Nimesulide Product
Table 204. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 205. Hainan Huluwa Pharmaceutical Corporation Information
Table 206. Hainan Huluwa Pharmaceutical Description and Business Overview
Table 207. Hainan Huluwa Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 208. Hainan Huluwa Pharmaceutical Nimesulide Product
Table 209. Hainan Huluwa Pharmaceutical Recent Developments/Updates
Table 210. Nanjing Zhengke Pharmaceutical Corporation Information
Table 211. Nanjing Zhengke Pharmaceutical Description and Business Overview
Table 212. Nanjing Zhengke Pharmaceutical Nimesulide Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 213. Nanjing Zhengke Pharmaceutical Nimesulide Product
Table 214. Nanjing Zhengke Pharmaceutical Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Nimesulide Distributors List
Table 218. Nimesulide Customers List
Table 219. Nimesulide Market Trends
Table 220. Nimesulide Market Drivers
Table 221. Nimesulide Market Challenges
Table 222. Nimesulide Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nimesulide
Figure 2. Global Nimesulide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nimesulide Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsule Product Picture
Figure 6. Granules Product Picture
Figure 7. Other Product Picture
Figure 8. Global Nimesulide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Nimesulide Market Share by Application in 2023 & 2030
Figure 10. Chronic Arthritis
Figure 11. Primary Dysmenorrhea
Figure 12. Traumatic Pain
Figure 13. Post-Operative Pain
Figure 14. Other
Figure 15. Global Nimesulide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Nimesulide Market Size (2019-2030) & (US$ Million)
Figure 17. Global Nimesulide Sales (2019-2030) & (KG)
Figure 18. Global Nimesulide Average Price (US$/G) & (2019-2030)
Figure 19. Nimesulide Report Years Considered
Figure 20. Nimesulide Sales Share by Manufacturers in 2023
Figure 21. Global Nimesulide Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Nimesulide Players: Market Share by Revenue in 2023
Figure 23. Nimesulide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Nimesulide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Nimesulide Sales Market Share by Country (2019-2030)
Figure 26. North America Nimesulide Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Nimesulide Sales Market Share by Country (2019-2030)
Figure 30. Europe Nimesulide Revenue Market Share by Country (2019-2030)
Figure 31. Germany Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Nimesulide Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Nimesulide Revenue Market Share by Region (2019-2030)
Figure 38. China Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Nimesulide Sales Market Share by Country (2019-2030)
Figure 49. Latin America Nimesulide Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Nimesulide Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Nimesulide Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Nimesulide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Nimesulide by Type (2019-2030)
Figure 59. Global Revenue Market Share of Nimesulide by Type (2019-2030)
Figure 60. Global Nimesulide Price (US$/G) by Type (2019-2030)
Figure 61. Global Sales Market Share of Nimesulide by Application (2019-2030)
Figure 62. Global Revenue Market Share of Nimesulide by Application (2019-2030)
Figure 63. Global Nimesulide Price (US$/G) by Application (2019-2030)
Figure 64. Nimesulide Value Chain
Figure 65. Nimesulide Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
